Topotecan Hydrochloride and Carboplatin With or Without Veliparib in Treating Advanced Myeloproliferative Disorders and Acute Myeloid Leukemia or Chronic Myelomonocytic Leukemia
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Center for International Blood and Marrow Transplant Research
Novartis
University of Washington
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
Massachusetts General Hospital
Dartmouth-Hitchcock Medical Center
Center for International Blood and Marrow Transplant Research
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
University of Rochester
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Chicago
Stanford University
City of Hope Medical Center
Thomas Jefferson University
Thomas Jefferson University
Incyte Corporation
Mayo Clinic
Constellation Pharmaceuticals
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
City of Hope Medical Center
Hangzhou GluBio Pharmaceutical Co., Ltd.
Barbara Ann Karmanos Cancer Institute
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
American Regent, Inc.
City of Hope Medical Center
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
University of Virginia
M.D. Anderson Cancer Center
University of Alabama at Birmingham
Fred Hutchinson Cancer Center
City of Hope Medical Center
AbbVie
Ohio State University Comprehensive Cancer Center
Epigenetix, Inc.
Stemline Therapeutics, Inc.
Astex Pharmaceuticals, Inc.
Astex Pharmaceuticals, Inc.
Fox Chase Cancer Center
Newave Pharmaceutical Inc
OHSU Knight Cancer Institute
Dartmouth-Hitchcock Medical Center